Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Total Liabilities (2016 - 2025)

InspireMD filings provide 16 years of Total Liabilities readings, the most recent being $14.2 million for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 32.48% to $14.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $14.2 million, a 32.48% increase, with the full-year FY2025 number at $14.2 million, up 32.48% from a year prior.
  • Total Liabilities hit $14.2 million in Q4 2025 for InspireMD, down from $14.4 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $14.4 million in Q3 2025 to a low of $4.7 million in Q1 2021.
  • Median Total Liabilities over the past 5 years was $7.0 million (2022), compared with a mean of $8.2 million.
  • Biggest five-year swings in Total Liabilities: dropped 2.83% in 2023 and later soared 57.26% in 2025.
  • InspireMD's Total Liabilities stood at $6.2 million in 2021, then grew by 17.48% to $7.3 million in 2022, then increased by 12.15% to $8.1 million in 2023, then skyrocketed by 31.68% to $10.7 million in 2024, then skyrocketed by 32.48% to $14.2 million in 2025.
  • The last three reported values for Total Liabilities were $14.2 million (Q4 2025), $14.4 million (Q3 2025), and $13.1 million (Q2 2025) per Business Quant data.